Trials / Completed
CompletedNCT01435811
Dose Range Evaluation of Norovirus Challenge Pool (GII.4, CIN-1)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Children's Hospital Medical Center, Cincinnati · Academic / Other
- Sex
- All
- Age
- 18 Years – 49 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine a suitable dose of the human norovirus GII.4 challenge pool(CIN-1;031693) that induces illness in approximately 50% of susceptible subjects that would be useful for evaluation of vaccines and antivirals.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Norovirus challenge pool (GII.4, CIN-1) | Norovirus challenge pool (GII.4, CIN-1) |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2012-04-01
- Completion
- 2012-11-01
- First posted
- 2011-09-19
- Last updated
- 2014-05-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01435811. Inclusion in this directory is not an endorsement.